<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33543">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02006719</url>
  </required_header>
  <id_info>
    <org_study_id>AUX-CC-871</org_study_id>
    <nct_id>NCT02006719</nct_id>
  </id_info>
  <brief_title>Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder</brief_title>
  <acronym>AC</acronym>
  <official_title>A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Auxilium Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Auxilium Pharmaceuticals</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this study are to assess the safety, effectiveness, and immunogenicity of
      AA4500 in the treatment of adhesive capsulitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study is a Phase 2b, double-blind, placebo-controlled study of the safety and efficacy of
      AA4500 for the treatment of adhesive capsulitis of the shoulder. To be eligible for
      treatment, a subject must have unilateral idiopathic adhesive capsulitis of the shoulder
      with restricted range of motion in the affected shoulder for at least 3 months but not more
      than 12 months. Subjects will be screened for study eligibility within 28 days before
      injection of study drug.

      Approximately 300 adult women and men are to be enrolled in this study. Following screening
      and determination of study eligibility, subjects will be randomized 3:1 to receive 0.58 mg
      of AA4500 or placebo.  Subjects will receive up to 3 injections of study drug.   Each
      injection will be separated by a minimum of 21 days. Subjects will also be instructed in
      home shoulder exercises after the first injection.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>The change (degrees) from baseline to the Day 95 follow-up in active forward flexion in the affected shoulder.</measure>
    <time_frame>Day 95</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline to Day 95 in American Shoulder and Elbow Surgeons Standardized Shoulder Assessment (ASES) function sub-scale</measure>
    <time_frame>Day 95</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change (degrees) from baseline to the Day 95 follow-up in abduction</measure>
    <time_frame>Day 95</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline to the Day 95 follow-up in pain with movement using a 11-point Visual Analogue Scale (VAS)</measure>
    <time_frame>Day 95</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change (degrees) from baseline to the Day 95 follow-up in internal rotation</measure>
    <time_frame>Day 95</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline to the Day 95 follow-up in external rotation</measure>
    <time_frame>Day 95</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline to the Day 95 follow-up in ASES pain sub-scale</measure>
    <time_frame>Day 95</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigator satisfaction with treatment at the Day 95 follow-up</measure>
    <time_frame>Day 95</time_frame>
    <safety_issue>No</safety_issue>
    <description>Degree of improvement in the severity of the subject's treated shoulder compared with screening assessed by questionnaire and rated as follows:
Very Much Improved
Much Improved
Minimally Improved
No Change
Minimally Worse
Much Worse
Very Much Worse</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject satisfaction with treatment at the Day 95 follow-up</measure>
    <time_frame>Day 95</time_frame>
    <safety_issue>No</safety_issue>
    <description>Determined by questionnaire and rated as follows:
Very Satisfied
Quite Satisfied
Neither Satisfied nor Dissatisfied
Quite Dissatisfied
Very Dissatisfied</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Adhesive Capsulitis</condition>
  <condition>Frozen Shoulder</condition>
  <arm_group>
    <arm_group_label>Collagenase Clostridium Histolyticum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Up to 3 injections of .58mg/1ml of CCH, minimum of 21 days apart and home shoulder exercise.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Up to 3 1ml injections of Placebo, minimum of 21 days apart and home shoulder exercise.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Collagenase Clostridium Histolyticum</intervention_name>
    <description>Treatment of Adhesive Capsulitis</description>
    <arm_group_label>Collagenase Clostridium Histolyticum</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>AA4500</other_name>
    <other_name>Xiaflex</other_name>
    <other_name>Xiapex</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Unilateral idiopathic adhesive capsulitis of one shoulder for at least 3 months but
             not more than 12 months (Frozen Stage)

          -  Normal range of motion in the contralateral shoulder

          -  Restricted active range of motion (AROM) in the affected shoulder defined as: a
             deficit of at least 60 degrees in total AROM in the affected shoulder as compared
             with the total AROM in the contralateral shoulder and a deficit of at least 30
             degrees in AROM in at least one of the following planes as compared with the
             contralateral shoulder:

               -  Forward flexion

               -  Abduction

               -  External rotation with the elbow up to 90 degrees abduction

               -  Internal rotation with the elbow up to 90 degrees abduction

        Exclusion Criteria:

          -  Has received treatment for adhesive capsulitis or is planning to receive treatment
             for adhesive capsulitis at any time during the study including but not limited to:

               -  physical therapy or acupuncture within 2 weeks before the first injection of
                  study drug

               -  intra-articular or intrabursal injection(s) of lidocaine; suprascapular nerve
                  blocks; corticosteroids, electroanalgesic and/or thermoanalgesic modalities
                  within 1 month before the screening visit

               -  intra-articular or intrabursal injection(s) of sodium hyaluronate and/or
                  glenohumeral distension arthrography within 3 months before the screening visit

               -  surgical intervention (including shoulder manipulation under anesthesia) at any
                  time

          -  Has any of the following conditions, as determined by investigator to be potentially
             confounding to the evaluation of safety and efficacy:

               -  Adhesive capsulitis as a result of traumatic injury (ie, direct injury to the
                  shoulder such as fracture of the humerus or clavicle immediately preceding the
                  onset of this episode of adhesive capsulitis).  Traumatic events in the past
                  that are not temporally related to the onset of this episode of adhesive
                  capsulitis would not necessarily exclude a subject from participating in the
                  study.

               -  Active subacromial impingement in the affected shoulder

               -  Calcified tendonitis in the affected shoulder

               -  Glenohumeral joint arthritis in the affected shoulder

               -  Arthrosis of the affected shoulder

               -  Chondrolysis of the affected shoulder

               -  Subscapularis tendon rupture of the affected shoulder

               -  Other rotator cuff injuries of the affected shoulder

               -  Uncontrolled hypertension

               -  Uncontrolled diabetes

               -  Uncontrolled thyroid disease

               -  History of thrombosis or post-thrombosis syndrome

               -  Physical impairment that would preclude performing the protocol defined
                  exercises

               -  Active infection in area to be treated

               -  Clinically significant neurological disease

               -  Bleeding disorder

               -  Chronic use of anticoagulation medications and the subject cannot be cleared
                  medically to stop taking medication for 7 days prior to each injection.  Less
                  than or equal to 150 mg aspirin is allowed during the study.

               -  Known active hepatitis A, B, or C

               -  Other significant medical condition (eg, morbid obesity, cervical disc disease),
                  which in the investigator's opinion would make the subject unsuitable for
                  enrollment in the study

          -  Has received oral or intravenous steroids for any reason within 3 weeks before the
             screening visit

          -  Has received an investigational drug or treatment within 30 days before the first
             dose of study drug.

          -  Has a known allergy to collagenase or any other excipient of AA4500 or any other
             procedural medication.

          -  Has, at any time, received collagenase for the treatment of adhesive capsulitis.

          -  Is unable to undergo an x-ray or MRI (contraindication) evaluation of the affected
             shoulder.

          -  Is planning to be treated with commercial XIAFLEX at any time during the study.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gregory Kaufman, MD</last_name>
    <role>Study Director</role>
    <affiliation>Auxilium Pharmaceuticals, Inc</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diane McCaul, BSRT R MR</last_name>
    <phone>484-321-2068</phone>
    <email>dmccaul@auxilium.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Alabama Orthopaedic Center-Research</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Robert Sorrell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Coastal Clinical Research</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36608</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Michael Granberry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arizona Research Center, Inc.</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85023</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Joseph Gimbel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Triwest Research Associates</name>
      <address>
        <city>El Cajon</city>
        <state>California</state>
        <zip>92020</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Louis Levy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Core Orthopedic Medical Center</name>
      <address>
        <city>Encinitas</city>
        <state>California</state>
        <zip>92024</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Farouk Awad</last_name>
      <phone>760-943-6710</phone>
      <phone_ext>162</phone_ext>
      <email>fawad@coreorthopaedic.com</email>
    </contact>
    <investigator>
      <last_name>Michael Skyhar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Temecula Rheumatology &amp; Internal Medicine</name>
      <address>
        <city>Murrietta</city>
        <state>California</state>
        <zip>92563</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Brigid Freyne</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Colorado Orthopedic Consultants, PC</name>
      <address>
        <city>Englewood</city>
        <state>Colorado</state>
        <zip>80110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Kim</last_name>
      <phone>303-695-6060</phone>
      <phone_ext>261</phone_ext>
    </contact>
    <investigator>
      <last_name>Philip Stull, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shrock Orthopedic Research, LLC</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33316</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Kevin Shrock, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Research of West Florida</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33603</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debbie Atkins, MS, CCRC</last_name>
      <phone>813-870-1292</phone>
      <phone_ext>127</phone_ext>
      <email>Datkins@crwf.com</email>
    </contact>
    <investigator>
      <last_name>Paul Lunseth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Non-Surgical Orthopedics, P.C. / Georgia Institute for Clinical Research, LLC</name>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>30060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Arnold Weil, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rockford Orthopedics Associates</name>
      <address>
        <city>Rockford</city>
        <state>Illinois</state>
        <zip>61114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica Torres, BSTM, CAN</last_name>
      <phone>815-484-6942</phone>
      <email>Monica.Torres@rockfordortho.com</email>
    </contact>
    <investigator>
      <last_name>Sean MacKenzie, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rockford Orthopedic Associates</name>
      <address>
        <city>Rockford</city>
        <state>Illinois</state>
        <zip>61107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica Torres, BSTM, CAN</last_name>
      <phone>815-484-6942</phone>
      <email>Monica.Torres@rockfordortho.com</email>
    </contact>
    <investigator>
      <last_name>Scott Trenhaile, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana Hand to Shoulder Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suzanne Cornelius</last_name>
      <email>FrozenShoulderStudy@ihtsc.com</email>
    </contact>
    <investigator>
      <last_name>Thomas Kaplan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bone and Joint Clinic</name>
      <address>
        <city>Gretna</city>
        <state>Louisiana</state>
        <zip>70056</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Craig Lucius, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MedPharmics, LLC</name>
      <address>
        <city>Metairie</city>
        <state>Louisiana</state>
        <zip>70006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Robert Jeanfreau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arthritis and Rheumatism Associates, PC</name>
      <address>
        <city>Wheaton</city>
        <state>Maryland</state>
        <zip>20902</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Paul J. DeMarco, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nevada Orthopedic &amp; Spine Center</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89128</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Edward Ashman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stony Brook University Medical Center (SUNY)</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen Euler</last_name>
      <phone>631-444-3421</phone>
      <email>Kathleen.Euler@stonybrookmedicine.edu</email>
    </contact>
    <contact_backup>
      <last_name>Gail Trocchio</last_name>
      <phone>631-444-2215</phone>
      <email>Gail.Trocchio@stonybrookmedicine.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Edward Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Triangle Orthopedic Associates, PA</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27704</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Joseph Wilson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Neuromusculoskeletal Center of the Cascades d.b.a. The Center</name>
      <address>
        <city>Bend</city>
        <state>Oregon</state>
        <zip>97701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meredith Dawson</last_name>
      <phone>541-382-3344</phone>
      <email>mdawson@thecenteroregon.com</email>
    </contact>
    <investigator>
      <last_name>James Verheyden, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Blair Orthopedic Associates, Inc.</name>
      <address>
        <city>Altoona</city>
        <state>Pennsylvania</state>
        <zip>16602</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vickie Lassak, RN CCRC</last_name>
      <phone>814-204-1191</phone>
      <email>Vlassak@blairortho.com</email>
    </contact>
    <investigator>
      <last_name>Shawn C. Saylor, D.O</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania Penn Orthopaedics</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19087</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Russell G. Huffman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John D. Kelly, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Orthopedic Specialist</name>
      <address>
        <city>Bedford</city>
        <state>Texas</state>
        <zip>76021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amber Morgan, CCRP</last_name>
      <phone>817-510-4022</phone>
      <email>Amber@txortho.net</email>
    </contact>
    <investigator>
      <last_name>Howard Harris, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Commonwealth Orthopaedics &amp; Rehabilitation</name>
      <address>
        <city>Arlington</city>
        <state>Virginia</state>
        <zip>22205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>John McConnell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Danville Orthopedic Clinic, Inc.</name>
      <address>
        <city>Danville</city>
        <state>Virginia</state>
        <zip>24541</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Mark Hermann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hunter Clinical Research</name>
      <address>
        <city>NSW</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Mark Russo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Prince Alfred</name>
      <address>
        <city>NSW</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Peter Youseff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St George Hospital</name>
      <address>
        <city>NSW</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>George Murrell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>QPharm</name>
      <address>
        <city>Queensland</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>David Gilpin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Peninsula Private Hospital</name>
      <address>
        <city>Queensland</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Anthony Houston, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Menzies Research Institute</name>
      <address>
        <city>Tasmania</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Graeme Jones, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emeritus Research</name>
      <address>
        <city>VIC</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Stephen Hall, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Epworth Hospital</name>
      <address>
        <city>VIC</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Repatriation Hospital</name>
      <address>
        <city>VIC</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Russell Buchanan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hand and Upper Limb Centre</name>
      <address>
        <city>WA</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Alex O'Beirne, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
    <country>Australia</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 23, 2014</lastchanged_date>
  <firstreceived_date>December 2, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Adhesive Capsulitis</keyword>
  <keyword>Frozen Shoulder</keyword>
  <keyword>Shoulder Range of Motion limitation</keyword>
  <keyword>Shoulder Pain</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bursitis</mesh_term>
    <mesh_term>Periarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
